Cargando…
Therapies to Suppress β Cell Autoimmunity in Type 1 Diabetes
Type 1 diabetes (T1D) is an autoimmune disease that is generally considered to be T cell-driven. Accordingly, most strategies of immunotherapy for T1D prevention and treatment in the clinic have targeted the T cell compartment. To date, however, immunotherapy has had only limited clinical success. A...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105696/ https://www.ncbi.nlm.nih.gov/pubmed/30166987 http://dx.doi.org/10.3389/fimmu.2018.01891 |